Likarda is a biotech company that provides enabling drug-delivery technologies using its proprietary Core-Shell Spherification (CSS) encapsulation platform. They partner with biotech, pharma, and research organizations to deliver solutions for small molecules, biologics, and cell therapies, with capabilities spanning therapeutic delivery, hydrogel encapsulation, and cryopreservation logistics. The company is advancing its manufacturing capabilities to support scalable encapsulation of biologics, cells, and small molecules, and operates globally from research and development through preclinical and clinical applications.
No recent deals for this company.